Occam Places Colin McCracken as CEO at Evonetix
Evonetix, a next generation synthetic biology company leveraging semiconductor technology to generate long, double-stranded DNA with high-fidelity at scale, has added Colin McCracken as CEO. To date, the UK-based platform company has raised $45M led by Foresite, DCVC, Draper Esprit and Morningside.
McCracken brings over twenty years’ experience in commercial and business development roles. Prior to joining Evonetix he was SVP & Chief Commercial Officer at Fluidigm where he was responsible for leading all commercial activities, driving revenue growth, and expanding the Company’s global reach. He has delivered commercial success in numerous leadership positions, including Vice President & General Manager and Vice President of Sales at Thermo Fisher Scientific, Vice President & Head of European Sales at Life Technologies and National Sales Manager at Qiagen.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.